Ostatní
Návod 
Ardelyx, Inc.
ARDX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.4B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-21
PS
3
Cena 1R
3-8
⌀ Cena
5.14
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
19-02-2026
Poslední dividenda
Profil
Ardelyx, Inc., biofarmaceutická společnost, objevuje, vyvíjí a komercializuje léčivé přípravky pro léčbu gastrointestinálních a kardiorenálních terapeutických oblastí ve Spojených státech a mezinárodně. Hlavní kandidátskou látkou společnosti je tenapanor, který dokončil fázi III klinického hodnocení léčby pacientů se syndromem dráždivého střeva se zácpou, stejně jako ve fázi III klinického hodnocení léčby sérového fosforu u dospělých pacientů s chronickým onemocněním ledvin (CKD) na dialýze nebo hyperfosfatémií. Vyvíjí se také RDX013, draselný sekretagog, pro léčbu zvýšené hladiny draslíku v séru, nebo hyperkalémie, což je problém u některých pacientů s onemocněním ledvin a/nebo srdce; a RDX020, program v raném stadiu metabolické acidózy, závažné poruchy elektrolytů u pacientů s chronickým renálním onemocněním. Společnost má dohody s Kyowa Kirin v Japonsku, Fosun Pharmaceutical Industrial Development Co. Ltd. v Číně a Knight Therapeutics, Inc. v Kanadě o vývoji a komercializaci tenapanoru na jejich příslušných územích. Společnost byla dříve známá jako Nteryx, Inc. a v červnu 2008 změnila své jméno na Ardelyx, Inc. Společnost Ardelyx, Inc. byla založena v roce 2007 a sídlí ve Walthamu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
395
Založení
2014-06-19
Podobné společnosti
$ 17.34
+ $ 0.88
$ 7.19
+ $ 0.10
$ 11.08
+ $ 0.07
$ 9.89
+ $ 0.37
$ 21.54
- $ 0.05
$ 7.35
- $ 0.51
$ 22.20
- $ 0.66
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 407.3 | 407.3 | 333.6 | 124.5 | 52.2 | 10.1 | 7.6 | 5.3 | 2.6 | 42.0 | 24.0 | 24.0 | 31.6 | 28.9 | 5.4 | |
| Cost of Revenues | 39.5 | 39.5 | 50.6 | 17.8 | 4.1 | 1.0 | 0.1 | 0.6 | 0.5 | 8.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 367.8 | 367.8 | 283.1 | 106.7 | 48.0 | 9.1 | 7.4 | 4.7 | 2.1 | 33.6 | 24.0 | 24.0 | 31.6 | 28.9 | 5.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 125.2 | 110.3 | 97.7 | 74.1 | 116.1 | 98.2 | 73.2 | 46.0 | 34.4 | 56.4 | |
| Cost of Revenues | 13.5 | 1.3 | 12.4 | 12.3 | 18.3 | 15.7 | 10.0 | 7.6 | 5.1 | 7.0 | |
| Gross Profit | 111.7 | 109.0 | 85.3 | 61.8 | 97.9 | 82.5 | 63.2 | 38.5 | 29.3 | 49.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 35.5 | 35.2 | 91.1 | 65.1 | 71.7 | 69.4 | 75.5 | 94.2 | 39.9 | 25.9 | 28.1 | 10.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 134.4 | 76.6 | 72.3 | 33.2 | 24.3 | 23.7 | 23.2 | 18.7 | 13.5 | 7.3 | 3.7 | 4.0 | |
| Depreciation & Amortization | 3.1 | 3.1 | 2.1 | 1.3 | 1.6 | 0.7 | 1.6 | 2.4 | 2.7 | 2.6 | 1.3 | 0.8 | 0.3 | 0.6 | 0.7 | |
| Total Operating Expenses | 408.8 | 408.8 | 311.0 | 169.9 | 111.8 | 163.4 | 98.2 | 95.9 | 93.1 | 98.7 | 112.9 | 53.4 | 33.2 | 31.8 | 14.2 | |
| Operating Income | -41.0 | -41.0 | -28.0 | -63.3 | -63.8 | -154.3 | -90.8 | -91.3 | -90.9 | -65.1 | -112.9 | -29.4 | -1.6 | -2.9 | -8.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.5 | 8.6 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.7 | 32.7 | ||
| Depreciation & Amortization | 0.9 | 0.9 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 0.4 | 0.4 | 1.2 | ||
| Total Operating Expenses | 106.6 | 104.3 | 99.7 | 98.2 | 89.7 | 80.3 | 76.8 | 63.1 | 57.3 | 41.3 | ||
| Operating Income | 5.1 | 4.7 | -14.4 | -36.3 | 8.1 | 2.2 | -13.6 | -24.7 | -28.0 | 7.4 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 28.4 | 28.4 | 20.1 | 8.9 | 5.1 | 4.5 | 5.1 | 5.7 | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -19.7 | -19.7 | -10.9 | -2.2 | -3.4 | -3.8 | -3.5 | -3.4 | 3.2 | 2.0 | 0.5 | -0.3 | -1.6 | -3.6 | -1.0 | |
| IBT | -60.6 | -60.6 | -38.9 | -65.5 | -67.2 | -158.2 | -94.3 | -94.6 | -91.3 | -63.2 | -112.4 | -29.7 | -3.1 | -6.4 | -9.8 | |
| Income Tax Expense | 1.0 | 1.0 | 0.3 | 0.5 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 1.2 | 0.0 | 0.0 | 0.1 | 0.1 | 1.0 | |
| Net Income | -61.6 | -61.6 | -39.1 | -66.1 | -67.2 | -158.2 | -94.3 | -94.9 | -91.3 | -64.3 | -112.4 | -29.6 | -3.2 | -6.6 | -9.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | ||
| Interest Expense | 9.8 | 5.8 | 6.6 | 6.3 | 5.9 | 5.3 | 4.9 | 4.1 | 2.8 | 2.0 | ||
| Other Expense | -5.5 | -5.5 | -4.7 | -3.9 | -3.4 | -3.0 | -2.8 | -1.7 | -0.5 | -0.6 | ||
| IBT | -0.4 | -0.9 | -19.1 | -40.3 | 4.7 | -0.8 | -16.4 | -26.4 | -28.5 | 6.8 | ||
| Income Tax Expense | 0.0 | 0.1 | 0.0 | 0.9 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | ||
| Net Income | -0.4 | -1.0 | -19.1 | -41.1 | 4.6 | -0.8 | -16.5 | -26.5 | -28.8 | 6.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.30 | $-0.42 | $-1.52 | $-1.05 | $-1.47 | $-1.62 | $-1.36 | $-2.80 | $-1.29 | $-0.31 | $-0.49 | $-0.73 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.30 | $-0.42 | $-1.52 | $-1.05 | $-1.47 | $-1.62 | $-1.36 | $-2.80 | $-1.29 | $-0.31 | $-0.49 | $-0.73 | |
| Shares Outstanding | 243.6 | 241.0 | 235.2 | 219.3 | 158.7 | 104.2 | 89.6 | 64.5 | 56.2 | 47.4 | 40.1 | 22.9 | 10.2 | 13.3 | 13.3 | |
| Diluted Shares Outstanding | 243.6 | 241.0 | 235.2 | 219.3 | 158.7 | 104.2 | 89.6 | 64.5 | 56.2 | 47.4 | 40.1 | 22.9 | 10.2 | 13.3 | 13.3 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.12 | $0.03 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.12 | $0.03 | ||
| Shares Outstanding | 243.6 | 241.9 | 239.9 | 238.6 | 237.4 | 235.9 | 234.6 | 233.1 | 232.3 | 222.8 | ||
| Diluted Shares Outstanding | 243.6 | 241.9 | 239.9 | 238.6 | 244.1 | 235.9 | 234.6 | 233.1 | 232.3 | 227.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 41.9 | 64.9 | 21.5 | 96.1 | 72.4 | 91.0 | 181.1 | 78.8 | 75.4 | 74.6 | 107.0 | 107.3 | 34.4 | 32.9 | |
| Short Term Investments | 144.1 | 185.2 | 162.8 | 27.8 | 44.3 | 95.5 | 66.4 | 89.3 | 58.6 | 126.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 186.0 | 250.1 | 184.3 | 123.9 | 116.7 | 186.5 | 247.5 | 168.1 | 134.0 | 200.8 | 107.0 | 107.3 | 34.4 | 32.9 | |
| Accounts Receivable | 37.2 | 57.7 | 22.0 | 7.7 | 0.5 | 0.0 | 0.8 | 5.1 | 10.8 | 0.0 | 0.0 | 2.6 | 6.4 | 3.1 | |
| Inventory | 13.8 | 21.2 | 12.4 | 3.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 26.1 | 27.5 | 27.3 | 5.1 | 17.6 | 8.8 | 4.1 | 4.5 | 5.1 | 3.2 | 5.2 | 1.4 | 1.0 | 0.9 | |
| Total Current Assets | 263.0 | 356.5 | 246.1 | 154.5 | 134.8 | 195.2 | 252.4 | 177.7 | 149.9 | 204.0 | 112.2 | 111.3 | 41.8 | 36.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 42.7 | 90.0 | 30.8 | 64.9 | 47.4 | 41.9 | 36.1 | 21.5 | 33.8 | 30.1 | |
| Short Term Investments | 200.0 | 148.4 | 183.1 | 185.2 | 143.0 | 144.1 | 166.4 | 162.8 | 131.3 | 97.5 | |
| Total Cash & ST Investments | 242.7 | 238.5 | 214.0 | 250.1 | 190.4 | 186.0 | 202.6 | 184.3 | 165.1 | 127.6 | |
| Accounts Receivable | 76.6 | 62.6 | 46.5 | 57.7 | 53.2 | 37.2 | 28.2 | 22.0 | 43.3 | 9.1 | |
| Inventory | 25.2 | 22.3 | 23.8 | 21.2 | 11.4 | 13.8 | 9.8 | 12.4 | 8.5 | 7.6 | |
| Other Current Assets | 23.5 | 28.3 | 28.5 | 27.5 | 29.1 | 26.1 | 17.4 | 27.3 | 24.3 | 17.8 | |
| Total Current Assets | 368.0 | 351.6 | 312.7 | 356.5 | 284.1 | 263.0 | 257.9 | 246.1 | 241.2 | 162.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 5.3 | 3.9 | 6.6 | 10.5 | 15.1 | 4.2 | 7.4 | 5.6 | 8.0 | 9.0 | 4.7 | 2.1 | 0.5 | 0.8 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 75.1 | 75.4 | 44.9 | 25.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.5 | 0.2 | |
| Total Long-Term Assets | 80.5 | 79.3 | 51.5 | 35.6 | 15.1 | 6.3 | 7.4 | 5.6 | 8.0 | 9.1 | 4.7 | 2.1 | 1.1 | 1.0 | |
| Total Assets | 343.5 | 435.8 | 297.6 | 190.1 | 149.9 | 201.6 | 259.8 | 183.3 | 157.9 | 213.1 | 116.9 | 113.4 | 42.9 | 37.9 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.2 | 7.1 | 5.3 | 3.9 | 4.7 | 5.3 | 5.7 | 6.6 | 7.6 | 8.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 111.0 | 108.1 | 92.2 | 75.4 | 79.1 | 75.1 | 78.8 | 44.9 | 40.5 | 41.0 | |
| Total Long-Term Assets | 118.2 | 115.2 | 97.5 | 79.3 | 83.8 | 80.5 | 84.4 | 51.5 | 48.2 | 49.1 | |
| Total Assets | 486.2 | 466.8 | 410.2 | 435.8 | 367.9 | 343.5 | 342.4 | 297.6 | 289.4 | 211.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.9 | 16.0 | 11.1 | 10.9 | 4.3 | 5.6 | 2.2 | 16.7 | 17.9 | 5.6 | 2.8 | 3.1 | 2.3 | 1.1 | |
| Short-Term Debt | 3.6 | 1.6 | 8.9 | 30.6 | 35.8 | 6.3 | 3.8 | -0.6 | 0.0 | 0.0 | 0.0 | -16.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 37.2 | 49.6 | 23.2 | 19.9 | 12.8 | 12.3 | 11.7 | 0.6 | 0.0 | 13.6 | 4.9 | 2.4 | 1.0 | 2.1 | |
| Current Liabilities | 62.4 | 77.8 | 50.4 | 74.6 | 57.5 | 28.4 | 22.2 | 17.7 | 17.9 | 19.2 | 7.7 | 5.6 | 17.1 | 16.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.4 | 21.7 | 13.7 | 16.0 | 15.8 | 10.9 | 17.3 | 11.1 | 7.7 | 5.3 | |
| Short-Term Debt | 1.4 | 1.2 | 1.3 | 1.6 | 2.6 | 3.6 | 4.3 | 8.9 | 8.6 | 35.3 | |
| Other Current Liabilities | 57.0 | 52.6 | 49.9 | 49.6 | 44.8 | 37.2 | 28.7 | 23.2 | 23.1 | 15.2 | |
| Current Liabilities | 83.4 | 81.7 | 75.8 | 77.8 | 70.5 | 62.4 | 56.9 | 50.4 | 43.5 | 61.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 100.2 | 151.9 | 51.5 | 5.9 | 9.7 | 47.0 | 50.9 | 49.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 1.1 | 2.6 | 6.2 | 9.7 | 13.2 | 2.5 | 4.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | -22.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 196.5 | 262.5 | 130.8 | 91.7 | 67.3 | 75.5 | 73.1 | 67.5 | 18.6 | 20.0 | 8.0 | 52.7 | 50.2 | 39.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 206.2 | 205.5 | 153.8 | 151.9 | 101.9 | 101.3 | 100.6 | 51.5 | 30.1 | 3.8 | |
| Capital Leases | 5.5 | 5.2 | 3.8 | 2.6 | 3.8 | 4.6 | 5.1 | 6.2 | 7.2 | 7.9 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.1 | 13.2 | |
| Total Liabilities | 331.9 | 327.2 | 264.5 | 262.5 | 209.6 | 196.5 | 191.5 | 130.8 | 98.2 | 88.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -889.2 | -885.3 | -846.2 | -780.1 | -712.9 | -554.8 | -460.5 | -365.5 | -278.2 | -213.9 | -101.5 | -71.9 | -68.7 | -62.1 | |
| Comprehensive Income | -0.1 | 0.1 | 0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -3.8 | -3.6 | -3.3 | -2.7 | |
| Total Common Equity | 147.0 | 173.3 | 166.8 | 98.3 | 82.6 | 126.1 | 186.7 | 115.8 | 139.3 | 193.2 | 108.9 | 60.7 | -7.3 | -1.2 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -946.5 | -945.6 | -926.5 | -885.3 | -890.0 | -889.2 | -872.7 | -846.2 | -817.4 | -824.0 | |
| Comprehensive Income | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | -0.1 | 0.0 | 0.2 | -0.2 | -0.2 | |
| Total Common Equity | 154.3 | 139.5 | 145.7 | 173.3 | 158.3 | 147.0 | 150.9 | 166.8 | 191.2 | 123.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 104.9 | 153.4 | 56.0 | 36.5 | 45.5 | 53.3 | 54.7 | 49.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 147.0 | 173.3 | 166.8 | 98.3 | 82.6 | 126.1 | 186.7 | 115.8 | 139.3 | 193.2 | 108.9 | 60.7 | -7.3 | -1.2 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 154.3 | 139.5 | 145.7 | 173.3 | 158.3 | 147.0 | 150.9 | 166.8 | 191.2 | 123.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -65.1 | -61.6 | -39.1 | -66.1 | -67.2 | -158.2 | -94.3 | -94.9 | -91.3 | -64.3 | -112.4 | -29.6 | -3.2 | -6.6 | -9.8 | |
| Depreciation & Amortization | 1.7 | 3.1 | 2.1 | 1.3 | 1.1 | 1.4 | 1.8 | 2.5 | 2.7 | 2.6 | 1.3 | 0.8 | 0.3 | 0.6 | 0.7 | |
| Stock-Based Compensation | 25.8 | 49.0 | 37.4 | 13.5 | 10.8 | 12.0 | 10.6 | 9.9 | 9.2 | 9.6 | 5.3 | 2.6 | 1.7 | 0.4 | 0.5 | |
| Change Working Capital | -51.1 | -31.4 | -49.2 | -43.4 | -19.6 | -11.9 | -3.2 | 3.0 | 9.4 | -13.7 | 12.8 | -46.2 | 13.0 | 3.9 | 29.7 | |
| Change In Accounts Receivable | -28.1 | -14.1 | -35.7 | -14.3 | -7.2 | -0.5 | 0.0 | 0.1 | 10.7 | -10.8 | 0.0 | 2.6 | 3.9 | -3.4 | -3.1 | |
| Change In Accounts Payable | 5.6 | 3.2 | 4.9 | 0.3 | 6.6 | -1.3 | 3.4 | 0.0 | -2.7 | -1.0 | 2.1 | -0.4 | 0.8 | 1.1 | -0.1 | |
| Change In Inventories | -35.5 | -31.9 | -41.7 | -21.1 | -28.3 | -10.4 | 0.0 | -3.4 | 1.9 | -1.9 | 0.0 | -2.1 | 0.7 | -0.7 | -0.6 | |
| Other Non-cash Items | 72.7 | -1.6 | 4.1 | 4.9 | 4.8 | 4.2 | 3.4 | 3.3 | 0.8 | 0.6 | 0.5 | 0.5 | 1.6 | 3.5 | 1.0 | |
| Cash from Operations | -85.3 | 0.0 | 0.0 | -89.7 | -70.0 | -152.6 | -81.4 | -76.5 | -70.3 | -65.2 | -92.5 | -71.8 | 13.4 | 1.8 | 22.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -0.4 | -1.0 | -19.1 | -41.1 | 4.6 | -0.8 | -16.5 | -26.5 | -28.8 | 6.6 | |
| Depreciation & Amortization | 0.9 | 0.9 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 0.4 | 0.4 | 0.3 | |
| Stock-Based Compensation | 0.0 | 12.7 | 11.7 | 12.1 | 9.9 | 9.1 | 10.8 | 7.6 | 3.9 | 3.5 | |
| Change Working Capital | 7.7 | -9.2 | -18.9 | -10.8 | -6.2 | -9.5 | -14.8 | -18.7 | 15.2 | -32.8 | |
| Change In Accounts Receivable | 4.8 | -14.1 | -16.1 | 11.2 | -4.5 | -16.0 | -9.1 | -6.1 | 21.2 | -34.2 | |
| Change In Accounts Payable | 0.8 | -3.3 | 8.0 | -2.3 | 1.2 | 3.9 | -6.4 | 6.1 | 3.4 | 2.4 | |
| Change In Inventories | 6.3 | -6.1 | -17.4 | -14.7 | -6.0 | -1.7 | -4.6 | -29.4 | -2.0 | 0.4 | |
| Other Non-cash Items | 12.8 | -3.1 | 0.3 | 0.8 | 1.0 | 1.1 | 0.5 | 1.4 | 0.1 | 0.9 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.7 | -21.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.5 | -1.5 | -1.0 | -0.3 | -0.1 | -1.9 | -0.3 | -0.3 | -0.3 | -2.4 | -4.9 | -3.5 | -1.9 | -0.3 | -0.1 | |
| Acquisitions | 62.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 31.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -184.0 | -218.9 | -195.2 | -215.2 | -50.3 | -72.7 | -150.9 | -102.7 | -169.0 | -84.0 | -133.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 143.2 | 211.5 | 177.9 | 84.3 | 67.0 | 125.6 | 119.7 | 126.4 | 139.5 | 151.7 | 7.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -40.8 | 0.0 | 0.0 | 0.0 | 1.8 | 0.0 | -31.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -41.3 | 0.0 | 0.0 | -131.2 | 18.4 | 50.9 | -31.4 | 23.4 | -29.9 | 65.3 | -131.1 | -3.5 | -1.9 | -0.3 | -0.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.4 | -0.2 | -0.7 | -0.3 | -0.6 | -0.1 | -0.1 | -0.2 | 0.0 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.5 | 32.5 | |
| Investments | -50.9 | -113.7 | -22.8 | -31.6 | -98.5 | -39.8 | -22.8 | -34.0 | -77.6 | -49.5 | |
| Sales of Investment | 55.0 | 63.3 | 58.4 | 34.7 | 57.5 | 42.2 | 46.5 | 31.6 | 48.1 | 17.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -29.5 | -32.5 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -29.6 | -32.7 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -75.6 | 0.0 | 0.0 | 22.4 | -33.0 | -19.4 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 145.6 | 153.4 | 97.5 | 41.9 | 24.0 | 11.6 | -1.3 | 5.5 | 49.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 62.8 | 0.0 | 0.0 | 119.2 | 71.6 | 101.1 | 21.0 | 154.9 | 53.8 | 0.7 | 190.6 | 74.3 | 61.2 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 4.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 135.2 | 0.0 | 0.0 | 4.7 | 36.8 | 1.3 | 1.9 | 0.6 | 49.8 | 0.0 | 0.6 | 0.7 | 0.1 | 0.0 | 0.3 | |
| Cash from Financing | 138.4 | 0.0 | 0.0 | 146.3 | 75.3 | 83.0 | 22.8 | 155.5 | 103.6 | 0.7 | 191.2 | 75.0 | 61.3 | 0.0 | 0.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 22.4 | 0.0 | |
| Debt Issued | 207.6 | 1.0 | 51.5 | 1.7 | 48.9 | -0.4 | 0.0 | 48.9 | 43.9 | -0.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 57.2 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.0 | 57.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 11.8 | 3.1 | 43.5 | -74.7 | 23.7 | -18.6 | -90.1 | 102.4 | 3.4 | 0.8 | -32.4 | -0.3 | 72.9 | 1.5 | 22.1 | |
| Closing Cash Balance | 41.9 | 68.0 | 64.9 | 21.5 | 96.1 | 72.4 | 91.0 | 181.1 | 78.8 | 75.4 | 74.6 | 107.0 | 107.3 | 34.4 | 32.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 25.3 | -47.3 | 59.2 | -34.1 | 17.5 | 5.5 | 5.7 | 14.7 | -12.3 | 3.7 | |
| Closing Cash Balance | 68.0 | 42.7 | 90.0 | 30.8 | 64.9 | 47.4 | 41.9 | 36.1 | 21.5 | 33.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -85.8 | -44.0 | -45.8 | -90.1 | -70.1 | -154.4 | -81.8 | -76.8 | -70.6 | -67.5 | -97.4 | -75.3 | 11.5 | 1.5 | 21.9 | |
| Real Free Cash Flow | -111.6 | -92.9 | -83.2 | -103.6 | -80.8 | -166.5 | -92.3 | -86.7 | -79.8 | -77.1 | -102.7 | -77.9 | 9.8 | 1.2 | 21.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 20.6 | 0.2 | -26.0 | -38.8 | 9.2 | 0.4 | -19.5 | -35.9 | -8.8 | -21.7 | |
| Real Free Cash Flow | 20.6 | -12.5 | -37.7 | -50.9 | -0.6 | -8.8 | -30.3 | -43.5 | -12.7 | -25.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -21 | -8.9 | -1.4 |
| P/S | 3.2 | 54.3 | 9.4 |
| P/B | 8.4 | 4.3 | 5.2 |
| P/FCF | -16.1 | -0.9 | -1.5 |
| Market cap | $1.4 | $58.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 16.1 % | 0 % |
| Debt to Income | -337 % | -55.5 % | 0 % |
| Debt to Free cash flow | -257.9 % | -106.6 % | 0 % |
| Interest expense percentage | -69.3 % | -8.1 % | 44.7 % |
| Current ratio | 4.4 | 6.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -39.9 % | -46.5 % | 0 % |
| ROA | -12.7 % | -37.2 % | 0 % |
| CapEx to Revenue | 0.4 % | 10.8 % | 0 % |
| RaD to Revenue | 0 % | 1463.8 % | 0 % |
| ROEM | 1,031,189.9 | 226895.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 90.3 % | 81.3 % | 68.7 % |
| Operating margin | -10.1 % | -1921.6 % | 35.5 % |
| Net margin | -15.1 % | -1964.4 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 243.6 mil | 98.0 mil |
| Employee count | 0.4 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
